Home Conference Coverage ASCO 2019

ASCO 2019

imaging increases RCC diagnoses

Imaging Increases RCC Diagnoses

renal cell cancer

Systemic Therapy after IO-VEGF

mRCC

Immune Checkpoint Therapy plus Cytoreductive Surgery

renal cell carcinoma

Immune Checkpoint Inhibitor Response in mRCC

costs of care

Costs of Episodes of Care in mRCC

combination therapy

First-line IO Combination Therapies in mRCC

kidney injury

Nivolumab plus Ipilimumab versus Sunitinib

Anxiety Associated with Mortality and Hospitalization in Patients on Dialysis

Atezolizumab plus Bevacizumab in Renal Cell Carcinoma

kidney injury

CheckMate 920: Efficacy and Safety Interim Results

Anxiety Associated with Mortality and Hospitalization in Patients on Dialysis

Pazopanib plus Nivolumab: PAZOREAL Results

Load more
Subscribe to RSS
Advertisement

#Trending in

click me